These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36388836)

  • 41. The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome.
    Zhang X; Zeng X; Dong L; Zhao X; Qu X
    World J Urol; 2015 Dec; 33(12):2071-7. PubMed ID: 25850975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of prostatic morphological parameters and clinical progression in aging Chinese men with benign prostatic hyperplasia: Results from a cross-sectional study.
    Qian S; Zhang S; Xia W; Xu D; Qi J; Shen H; Wu Y
    Prostate; 2021 Jun; 81(8):478-486. PubMed ID: 33860949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High indirect bilirubin levels as an independent predictor of postoperative myasthenic crisis: a single-center, retrospective study.
    Sun C; Ruan Z; Zhang Y; Guo R; Li H; Wang T; Gao T; Tang Y; Song N; Hao S; Huang X; Li S; Ning F; Su Y; Lu Q; Wang Q; Cao X; Li Z; Chang T
    Front Neurol; 2023; 14():1336823. PubMed ID: 38283685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia.
    Khan S; Wolin KY; Pakpahan R; Grubb RL; Colditz GA; Ragard L; Mabie J; Breyer BN; Andriole GL; Sutcliffe S
    BMC Urol; 2021 Mar; 21(1):47. PubMed ID: 33773592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.
    Roehrborn CG; Boyle P; Gould AL; Waldstreicher J
    Urology; 1999 Mar; 53(3):581-9. PubMed ID: 10096388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate volume correlates with diabetes in elderly benign prostatic hyperplasia patients.
    Qu X; Huang Z; Meng X; Zhang X; Dong L; Zhao X
    Int Urol Nephrol; 2014 Mar; 46(3):499-504. PubMed ID: 24022843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential role of glutathione S-transferase P1 gene polymorphism and metabolic syndrome in lower urinary tract symptoms attributed to benign prostatic hyperplasia.
    Zhang W; Li Z; Liu M; Mu Y; He J; Chen P; Liu D; Chen K; Che B; Xu S; Zhang H; Tang K
    World J Urol; 2021 Dec; 39(12):4413-4419. PubMed ID: 34228163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated red blood cell distribution width in benign prostatic hyperplasia patients with metabolic syndrome.
    Dong X; Liao Y; Chen K; Fang Y; Li W; Chen J; You L; Li S
    Int J Clin Exp Med; 2015; 8(1):1213-9. PubMed ID: 25785115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum Bilirubin Levels and Extent of Symptomatic Intracranial Atherosclerotic Stenosis in Acute Ischemic Stroke: A Cross-Sectional Study.
    Yu F; Zhang L; Liao D; Luo Y; Feng X; Liu Z; Xia J
    Front Neurol; 2021; 12():714098. PubMed ID: 34512527
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
    Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
    BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative analysis of resected prostate weight in diabetic and non-diabetic benign prostatic hyperplasia Patients.
    Moudi E; Akbarzadeh-Pasha A
    Caspian J Intern Med; 2017; 8(2):99-103. PubMed ID: 28702148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation between prostate volume and prostate-specific antigen in Nigerian men with symptomatic histologically-diagnosed benign prostatic hyperplasia.
    Aigbe E; Irekpita E; Ogbetere FE; Alili UI
    Niger J Clin Pract; 2022 Sep; 25(9):1523-1528. PubMed ID: 36149214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlates of low density lipoprotein cholesterol: associations with physical, chemical, dietary, and behavioral characteristics.
    Schwarz W; Trost DC; Reiland SL; Rifkind BM; Heiss G
    Arteriosclerosis; 1982; 2(6):513-22. PubMed ID: 6983877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups.
    Wu O; Leng JH; Yang FF; Yang HM; Zhang H; Li ZF; Zhang XY; Yuan CD; Li JJ; Pan Q; Liu W; Ren YJ; Liu B; Liu QM; Cao CJ
    Clin Exp Hypertens; 2018; 40(1):16-21. PubMed ID: 29083240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated serum bilirubin levels are associated with improved survival in patients with curatively resected non-small-cell lung cancer.
    Li N; Xu M; Cai MY; Zhou F; Li CF; Wang BX; Ou W; Wang SY
    Cancer Epidemiol; 2015 Oct; 39(5):763-8. PubMed ID: 26159684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Body mass index in relation to prostate-specific antigen-related parameters.
    Lin D; Liu T; Chen L; Chen Z
    BMC Urol; 2021 Sep; 21(1):130. PubMed ID: 34530776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxidised low-density lipoprotein, a possible distinguishing lipid profile biomolecule between prostate cancer and benign prostatic hyperplasia.
    Asare GA; Owusu-Boateng E; Asiedu B; Amoah BY; Essendoh E; Otoo RY
    Andrologia; 2019 Sep; 51(8):e13321. PubMed ID: 31145504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
    Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
    Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.